Serum level of follicle-stimulating hormone is associated with extraprostatic extension of prostate cancer

Selective expression of FSH receptor on the surface of blood vessels of prostate cancers has recently been reported. Measuring serum FSH preoperatively in patients with prostate cancer may provide clinically relevant information about extraprostatic spread of tumor.